Package 69367-288-05

{"route": ["ORAL"], "spl_id": "19bc8511-a58b-da1c-e063-6394a90a5111", "openfda": {"upc": ["0369367289092", "0369367288095"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["c280efb9-b284-6a69-e053-2995a90a3035"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-288-05)", "package_ndc": "69367-288-05", "marketing_start_date": "20180529"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-288-09)", "package_ndc": "69367-288-09", "marketing_start_date": "20171001"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "69367-288_19bc8511-a58b-da1c-e063-6394a90a5111", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "69367-288", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA207224", "marketing_category": "ANDA", "marketing_start_date": "20171001", "listing_expiration_date": "20261231"}